Skip to main content

Advertisement

SpringerLink
Log in

Chronic Urticaria: Comparisons of US, European, and Asian Guidelines

  • Allergic Skin Diseases (L Fonacier, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Chronic urticaria is a common dermatological condition that has significant impact on quality of life. Multiple international societies have published guidelines, and although these guidelines generally agree on the definition of urticaria, as well as approach to diagnosis and management, there have been notable differences to date. These differences have been reconciled by the recent publication of the 2017 revision and update published by the EAACI/GA2LEN/EDF/WAO.

Recent Findings

The 2017 revision and update to the guidelines for chronic urticaria are the most comprehensive consensus document to date, and reconcile previously existing differences between the US, European, and Asian guidelines.

Summary

The purpose of our review is to present basic background on urticaria and discuss classification, diagnosis, and most importantly, management. We present differences from previous US, European, and Asian guidelines and reconcile the previous differences by summarizing the 2017 revision and update published by the EAACI/GA2LEN/EDF/WAO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of Particular Interest, Published Recently, Have Been Highlighted as: • of Importance •• of Major Importance

  1. Kaplan A. Clinical practice: chronic urticaria and angioedema. NEJM. 2002;64:1427–43.

    Google Scholar 

  2. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2014;69(7):e1–29.

    Article  PubMed  CAS  Google Scholar 

  3. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105:664–72.

    Article  PubMed  CAS  Google Scholar 

  4. Zuberbier T, Balke M, Worm M, Edenharter G, Maurer M. Epidemiology of urticaria: a representative cross-sectional population survey. Clin Exp Dematol. 2010;35:869–73.

    Article  CAS  Google Scholar 

  5. Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D, et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy. 2004;59(8):869–73.

    Article  PubMed  CAS  Google Scholar 

  6. Amin P, Levin L, Holmes SJ, Picard J, Bernstein JA. Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria. J Allergy Clin Immunol Pract. 2015;3(3):400–7.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Poulos LM, Waters AM, Pop Htlh GD, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol. 2007;120:878–84.

    Article  PubMed  Google Scholar 

  8. O’ Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on quality of life. Brit J of Dermatol. 1997;136(2):197–201.

    Article  Google Scholar 

  9. • Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J allergy Clin Immunol. 2014;133:1270–7. Practice parameters outlining the 2014 US guidelines on the diagnosis and management of chronic urticaria

    Article  PubMed  Google Scholar 

  10. • Zuberbier T, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW, Church MK. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014: 69: 868-87. Document outlining the 2013 European guidelines on the diagnosis and management of chronic urticaria.

  11. •• Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2017 revision and update. Allergy 2018: Epub ahead of print. 2017 revision and update to urticaria guidelines, the most comprehensive consensus document to date.

  12. • Chow SK. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Allergy. 2012;2:149–60. Document outlining the 2010 Asian guidelines on the diagnosis and management of chronic urticaria

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hide M, Hiragun T. Japanese guidelines for diagnosis and treatment of urticaria in comparison with other countries. Allergol Int. 2012;61:517–27.

    Article  PubMed  Google Scholar 

  14. Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria. Allergy. 2008;63:777–80.

    Article  PubMed  CAS  Google Scholar 

  15. Weller KG, Magerl M, Tohme M, Martus N, Krause P, Metz K, et al. Development, validation, and initial results of the angioedema activity score. Allergy. 2013;68(9):1185–92.

    PubMed  CAS  Google Scholar 

  16. Weller K, Groffik A, Church MK, Hawro T, Krause K, Metz M, et al. Development and validation of the urticaria control test: a patient-reported outcome instrument for assessing urticaria control. J Allergy Clin Immunol. 2014;133(5):1365–72.

    Article  PubMed  Google Scholar 

  17. Ohanyan T, Schoepke N, Bolukbasi B, Metz M, Hawro T, Zuberbier T, et al. Responsiveness and minimal important difference of the urticaria control test. J Allergy Clin Immunol. 2017;140(6):1710–3.

    Article  PubMed  Google Scholar 

  18. Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy and Clin Immunol. 2015;136(2):245–51.

    Article  CAS  Google Scholar 

  19. Tarbox JA, Gutta RC, Radojicic C, Lang DM. Utility of routine laboratory testing in management of chronic urticaria/angioedema. Ann Allergy Asthma Immunol. 2011;107:239–43.

    Article  PubMed  Google Scholar 

  20. Magerl M, Pisurevokaja D, Scheufele R, Zuberbier T, Manner M. Effects pf pseudoallergen diet on chronic spontaneous urticaria: a prospective trial. Allergy. 2010;65:78–83.

    Article  PubMed  CAS  Google Scholar 

  21. Maurer M, Keller W, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, Bousquet J, et al. Unmet clinical needs in chronic spontaneous urticaria. A Galen task force report. Allergy. 2010;66:317–30.

    Article  PubMed  Google Scholar 

  22. • Sanchez-Borges M, Asero R, Ansotegui IJ, Baiardino I, Bernstein JA, Canonica GW, et al. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. WAO Journal. 2012;5:125–47. Document outlining the 2012 global guidelines on the diagnosis and management of chronic urticaria

    PubMed  PubMed Central  Google Scholar 

  23. Handa S, Dogra S, Kumar B. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat. 2004;15:55–7.

    Article  PubMed  CAS  Google Scholar 

  24. Potter PC, Kapp A, Maurer M, Guillet G, Jian AM, Hauptmann P, et al. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Allergy. 2009;64:596–604.

    Article  PubMed  CAS  Google Scholar 

  25. Zuberbier T, Oanta A, Bogacka E, Medina I, Wesel F, Uhl P, et al. Comparison of the efficacy and safety of bilastine 20 mg versus levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-Centre, double-blind, randomized, placebo-controlled study. Allergy. 2010;65:516–28.

    Article  PubMed  CAS  Google Scholar 

  26. Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol. 2002;88:190–7.

    Article  PubMed  CAS  Google Scholar 

  27. Staevska M, Popov TA, Kralimarkova T, Lazarova C, Kraeva S, Popova D. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125:676–82.

    Article  PubMed  CAS  Google Scholar 

  28. Asero R. Chronic unremitting urticaria: is the use of antihistamine above licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol. 2007;32:34–8.

    Article  PubMed  CAS  Google Scholar 

  29. Monroe EW. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Clin Ther. 1992;14:17–21.

    PubMed  CAS  Google Scholar 

  30. Schweitzer PK, Muehlbach MJ, Walsh JK. Sleepiness and performance during three-day administration of cetirizine or diphenhydramine. J Allergy Clin Immunol. 1994;94:716–24.

    Article  PubMed  CAS  Google Scholar 

  31. Nettis E, Dambra P, D’Oronzio L, Loria MP, Ferrannino A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol. 2001;137:99–100.

    PubMed  CAS  Google Scholar 

  32. Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol. 2004;113:134–40.

    Article  PubMed  CAS  Google Scholar 

  33. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy. 2004;34:1401–7.

    Article  PubMed  CAS  Google Scholar 

  34. Sanada S, Tanaka T, Kameyoshi Y, Hide M. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria. Arch Dermtol Res. 2005;297:134–8.

    Article  CAS  Google Scholar 

  35. DiLorenzo G, D’Alcamo A, Rizzo M, Leto-Barone MS, Bianco CL, DItta V, et al. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systemic review. J Asthma Allergy. 2008;9:9–16.

    Article  Google Scholar 

  36. Harvey PR, Wegs J, Shocket AL. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol. 1981;68:262–6.

    Article  PubMed  CAS  Google Scholar 

  37. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404–7.

    Article  PubMed  CAS  Google Scholar 

  38. Bleehan SS, Thomas SE, Greaves MW, Newton J, Kennedy CT, Hindley F, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-Centre randomized double-blind study. Br J Dermatol. 1987;117:81–8.

    Article  Google Scholar 

  39. Paul E, Bodeker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized, double-blind study in 45 patients. Eur J Clin Phamacol. 1986;31:277–80.

    Article  CAS  Google Scholar 

  40. Sharpe GR, Shuster R. In dermographic urticaria H2 receptor antagonists have a small but therapeutically irrelevant additional effect compared to H1 antagonists alone. Br J Dermatol. 1993;129:575–9.

    Article  PubMed  CAS  Google Scholar 

  41. Salo OP, Kauppinen K, Mannisto PT. Cimetidine increases the plasma concentration of hydroxyzine. Acta Derm Venereol. 1986;66:349–50.

    PubMed  CAS  Google Scholar 

  42. Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H2 antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol. 1995;95:685–93.

    Article  PubMed  CAS  Google Scholar 

  43. • Khan DA. Alternative agents in refractory chronic urticaria: evidence and considerations on the selection and use. J Allergy Clin Immunol Prac. 2013;1:433–40. Review of alternative agents used in the management of refractory cases of chronic urticaria

    Article  Google Scholar 

  44. Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, et al. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H-1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011;128(3):567–U195.

    Article  PubMed  CAS  Google Scholar 

  45. •• Maurer M, Rosen K, Hsieh HJ, Saini S, Grattan C, Gimenez-Arnau A, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924–35. Landmark study demonstrating the efficacy of omalizumab in chronic urticaria

    Article  PubMed  CAS  Google Scholar 

  46. Zhao ZT, Ji CM, Yu WJ, Meng L, Hawro T, Wei JF, et al. Omalizumab for the treatment of chronic spontaneous urticaria: a meta-analysis of randomized clinical trials. J Allergy Clin Immunol. 2016;137(6):1742–50.

    Article  PubMed  CAS  Google Scholar 

  47. Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. 2000;143(2):365–72.

    Article  PubMed  CAS  Google Scholar 

  48. Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. 2006;55(4):705–9.

    Article  PubMed  Google Scholar 

  49. • Kulthanan K, Chaweekulrat P, Komoltri C, Hunnangkul S, Tuchinda P, Chularojanamontri L, et al. Cyclosporine for chronic spontaneous urticaria: a meta-analysis and systematic review. J Allergy Clin Immunol Pract. 2018;6(2):586–99. Meta-analysis reviewing the literature for cyclosporine in refractory cases of chronic urticaria

    Article  PubMed  Google Scholar 

  50. Yang K. Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids. Rev Reprod. 1997;2:129–32.

    Article  PubMed  CAS  Google Scholar 

  51. Ost L, Wettrell G, Bjorkman I, Rane A. Prednisolone excretion in human milk. J Pediatr. 1985;106:1008–11.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Allergy and Clinical Immunology, Rochester Regional Health, Rochester, NY, USA

    S. Shahzad Mustafa

  2. University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

    S. Shahzad Mustafa

  3. Allergy and Clinical Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela

    Mario Sánchez-Borges

Authors
  1. S. Shahzad Mustafa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Sánchez-Borges
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Shahzad Mustafa.

Ethics declarations

Conflict of Interest

S. Shahzad Mustafa declared that he is on the speaker's bureau for Genentech.

Mario Sánchez-Borges declared that no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Allergic Skin Diseases

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahzad Mustafa, S., Sánchez-Borges, M. Chronic Urticaria: Comparisons of US, European, and Asian Guidelines. Curr Allergy Asthma Rep 18, 36 (2018). https://doi.org/10.1007/s11882-018-0789-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-018-0789-3

Keywords

Search

Navigation